Wellnex Life Ltd (ASX: WNX) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Wellnex Life Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Wellnex Life Ltd (ASX: WNX)
Latest News
Growth Shares
Are these ASX shares the next a2 Milk Company?
Share Gainers
Why Afterpay, Praemium, Wattle Health, & WPP shares raced higher today
ASX Share Market News
Why the Wattle Health share price stormed higher today
ASX Share Market News
Wattle Health updates market on B&P acquisition
Share Fallers
Bellamy's, a2 Milk, Bubs shares sink on China's new baby formula rules
Share Fallers
Should you buy BWX and these beaten down ASX shares?
Share Gainers
ALL ORDINARIES finishes higher Thursday: 8 shares you missed
Share Gainers
Why FlexiGroup, Orica, Qantas, & Wattle Health shares surged higher today
Share Gainers
Why the Wattle Health share price stormed 13% higher today
ASX Share Market News
Will the Bubs Australia share price fall after its acquisition?
ASX Share Market News
Bubs Australia share price on watch after selling non-core assets
Share Gainers
Why the Wattle Health share price is charging higher today
WNX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Wellnex Life Ltd
Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes on production of dairy products focuses on infant formula and dried dairy goods. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.
WNX Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 20 Nov 2026 | $0.06 | $0.00 | 0.00% | 121 | $0.06 | $0.06 | $0.06 |
| 19 Nov 2026 | $0.06 | $0.00 | 0.00% | 600 | $0.06 | $0.06 | $0.06 |
| 18 Nov 2026 | $0.06 | $0.00 | 0.00% | 10,000 | $0.06 | $0.06 | $0.06 |
| 16 Nov 2026 | $0.06 | $0.00 | 0.00% | 4,600 | $0.06 | $0.06 | $0.06 |
| 13 Nov 2026 | $0.06 | $0.00 | 0.00% | 9,000 | $0.06 | $0.06 | $0.06 |
| 11 Nov 2026 | $0.06 | $0.00 | 0.00% | 113,054 | $0.06 | $0.06 | $0.06 |
| 10 Nov 2026 | $0.06 | $0.00 | 0.00% | 975 | $0.06 | $0.06 | $0.06 |
| 06 Nov 2026 | $0.06 | $0.00 | 0.00% | 508 | $0.06 | $0.06 | $0.06 |
| 05 Nov 2026 | $0.06 | $0.00 | 0.00% | 118 | $0.06 | $0.06 | $0.06 |
| 04 Nov 2026 | $0.06 | $0.00 | 0.00% | 57,979 | $0.06 | $0.06 | $0.06 |
| 30 Oct 2026 | $0.07 | $0.00 | 0.00% | 105,500 | $0.07 | $0.07 | $0.07 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Sep 2026 | Jeffrey Yeh | Sell | 4,322,886 | $345,830 |
Off-market trade. As per announcement
|
| 22 Dec 2025 | Jeffrey Yeh | Transfer | 890,609 | $89,060 |
Off-market transfer. $ 732,795.85
|
| 22 Dec 2025 | Jeffrey Yeh | Transfer | 1,285,409 | $128,540 |
As advised by the company. $ 732,795.85
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Eric Jiang | Executive DirectorInterim Chairman | Mar 2026 |
Mr Jiang has over 15 years of experience with companies involved in trade between Australia and China, including experience relating to the cultural, economic and strategic context in which Australian businesses engage with China.
|
| Mr Jeffrey Yeh | Non-Executive Director | Jan 2024 |
Mr Jeffrey Yeh has over 21 years of experience in the pharmaceutical sector, including experience in sales, marketing, production, quality assurance, operations, logistics, finance and management.
|
| Mr Ash Vesali | Non-Executive Director | Sep 2025 |
Mr Vesali has over 20 years of experience across high-volume manufacturing and consulting, including experience in strategy, governance, performance improvement, business resiliency, operational improvement, capital allocation, international expansion and strategic partnerships.
|
| Mr Hilton Keith Wood | Non-Executive Director | Jun 2026 |
Mr Hilton has over 30 years of experience in banking and finance across institutional banking, corporate relations and international markets. His experience includes work with companies in a consulting capacity.
|
| Mr Zheng (Kobe) Li | Company Secretary | Jan 2019 |
-
|
| Zheng (Kobe) Li | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Computershare Clearing Pty Ltd (CCNL DI A/C) | 12,555,370 | 17.19% |
| Citicorp Nominees Pty Limited | 4,239,671 | 5.81% |
| Reach Investment Group Nominees Pty Ltd (R Markets Unit A/C) | 2,930,159 | 4.01% |
| JYSF Management Pty Ltd (JYSF A/C) | 2,629,181 | 3.60% |
| Finclear Services Pty Ltd (Superhero Securities A/C) | 2,086,413 | 2.86% |
| Lotus Capital Group Pty Ltd | 1,398,567 | 1.92% |
| Kobella Holdings Pty Ltd (The Kobella Holding Unit A/C) | 1,371,429 | 1.88% |
| AppWAM Pty Ltd | 1,100,000 | 1.51% |
| Acorn Management Investments Pty Ltd (Strategic Small Caps A/C) | 1,076,578 | 1.47% |
| Major Halfpenney Pty Ltd (Palfreman Family S/F A/C) | 1,053,846 | 1.44% |
| Mr Reid Jon Zulpo and Mrs Melissa Catherine Zulpo (RJ & MC Zulpo Family A/C) | 1,009,650 | 1.38% |
| JYSF Management Pty Ltd (JYSF A/C) (I) | 890,609 | 1.22% |
| 365 Health Australia Pty Ltd | 883,996 | 1.21% |
| Bengal Capital Pty Ltd (Bengal Capital Family A/C) | 829,446 | 1.14% |
| Kirby Superannuation Pty Ltd (Kirby Super Fund A/C) | 803,096 | 1.10% |
| HSBC Custody Nominees (Australia) Limited (A/C 2) | 700,717 | 0.96% |
| ZLJ Pty Ltd (The Bozinovski Family A/C) | 667,473 | 0.91% |
| PAIF Pty Ltd (PAIF Fund A/C) | 654,817 | 0.90% |
| GGP Investments Pty Ltd (GGP Superannuation Fund A/C) | 654,656 | 0.90% |
| 28225 Pty Ltd (HMNJ A/C) | 626,914 | 0.86% |